Spike S1 (B.1.1.7; Alpha Variant) (SARS-CoV-2) : ACE2 TR-FRET Assay Kit
The Spike S1 (B.1.1.7; Alpha Variant) (SARS-CoV-2) : ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (B.1.1.7; Alpha Variant) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) .
Product Specifications
Background
Applications
This kit is useful for screening for inhibitors of the interaction between SARS-CoV-2 Spike S1 (B.1.1.7; Alpha Variant) and human ACE2.
Format
Shipping Conditions
-80°C
Storage Conditions
This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed.
Notes
Contraindications
Keep final DMSO concentration at or below 1%.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items